GV-backed One Medical owner 1Life has filed to go public, setting a placeholder target of $100m, having raised $400m in equity financing.

The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.

Pieces Technology, a medical intelligence technology provider that counts OSF Healthcare and Children’s Health among its investors, has secured $25.7m.

The Illumina and Amgen-backed genetic sequencing system developer raised $38.5m while its shareholders sold another $106m in shares.

In an extended version covering the holidays, Global Corporate Venturing has rounded up the period’s smaller deals and tracked the emerging companies accessing corporate funds.

The Legend Capital-backed radiology-imaging technology provider received $23m in a series B round led by Sherpa Venture Capital.

Bic Camera, Brother Industries, Hi-Lex, Nac, TIS, Tokai and Towa were among the backers that supplied $32.3m for TUS spinout Innophys' series C funding.

The health product developer has now raised more than $71m in debt and equity financing in total having received series C funding from backers including Mayo Clinic Ventures.

Tencent, Parkway Global and returning investor Lilly Asia Ventures all contributed to a series B round that boosted the cancer immunotherapy developer's total funding to $155m.

Lilly Asia Ventures and SBCVC both invested in the cancer diagnostics technology developer as part of a round that will fund research and development and strategic partnerships.